Overview
Tholkappiyan Ramachandran practices practicing medicine in Bengaluru, India.
Their clinical expertise encompasses Conversion Disorder and Pancreatic Ductal Adenocarcinoma.
They are actively involved in clinical research, co-authoring 48 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tholkappiyan V. Ramachandran
Is Tholkappiyan V. Ramachandran a top-rated expert for Conversion Disorder?
MediFind is an objective health platform that identifies experts based on real-world data. Tholkappiyan V. Ramachandran is classified as an Experienced expert for Conversion Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tholkappiyan V. Ramachandran participate in research or clinical trials?
Yes. Tholkappiyan V. Ramachandran has published 48 articles and abstracts on conditions like Conversion Disorder. You can view a list of Tholkappiyan V. Ramachandran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Conversion DisorderRamachandran isExperienced. Learn about Conversion Disorder.
- Pancreatic Ductal AdenocarcinomaRamachandran isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.